Lexeo Therapeutics | SC 13G:超过5%持股股东披露文件-Adage Capital Management, L.P.(7.86%),Robert Atchinson(7.86%)等
Lexeo Therapeutics | 4:持股变动声明-高管 Townsend Richard Nolan
Lexeo Therapeutics | 4:持股变动声明-高管 Townsend Richard Nolan
Lexeo Therapeutics | 4:持股变动声明-高管 Townsend Richard Nolan
Lexeo Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Eventide Asset Management, LLC(6.65%),Finny Kuruvilla, M.D. Ph. D.(6.65%)等
Lexeo Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Janus Henderson Group plc(10.3%),Janus Henderson Biotech Innovation Master Fund Ltd(5.1%)
Lexeo Therapeutics | 4:持股变动声明-高管 Townsend Richard Nolan
Lexeo Therapeutics | 4:持股变动声明-董事 Van Hauwermeiren Timothy
Lexeo Therapeutics | 3:首次持股声明-董事 Van Hauwermeiren Timothy
Lexeo Therapeutics | 4:持股变动声明-董事 COOPERSTONE BRENDA
Lexeo Therapeutics | 4:持股变动声明-董事 Altschuler Steven
Lexeo Therapeutics | 4:持股变动声明-董事 DIAZ REINALDO M
Lexeo Therapeutics | 4:持股变动声明-董事 Agger Mette Kirstine
Lexeo Therapeutics | 4:持股变动声明-董事 CHOLMONDELEY PAULA H
Lexeo Therapeutics | 4:持股变动声明-高管 Otero Jose Manuel
Lexeo Therapeutics | 4:持股变动声明-高管 Townsend Richard Nolan
Lexeo Therapeutics | 3:首次持股声明-高管 Otero Jose Manuel
Lexeo Therapeutics | 4:持股变动声明-高管 Townsend Richard Nolan
Lexeo Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Citadel Advisors LLC(7.8%),Citadel Advisors Holdings LP(7.8%)等
Lexeo Therapeutics | SC 13G:超过5%持股股东披露文件
暂无数据
暂无数据